《大行報告》瑞銀上調普拉達(01913.HK)目標價至62元 評級「買入」
瑞銀髮表研究報告指,普拉達(01913.HK)的股價於過去一年表現都跑贏同業,預期趨勢將持續。
該行指,看好收入及盈利有上升空間,對2021年預測較市場預期高出8%及11%,明年預測更高出10%及18%。該行指公司有成熟的分店網絡,成本效益具規模,預期至2023年毛利率可提升至78%,創紀錄新高。
瑞銀估計,至2025年普拉達銷售額將達到46億歐元,即2021至2024年複合增長率達到11%,高於板塊的7%,並預期EBIT利潤率可達21.9%,將2021至2023年每股盈利預測相應上調7%、5%及3%,給予「買入」評級,目標價升13%至62元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.